Literature DB >> 21288477

Quiescence regulators for hematopoietic stem cell.

June Li1.   

Abstract

Hematopoietic stem cell (HSC) either stays in quiescence or proliferates toward differentiation for the production of mature blood cells, or toward self-renewal for giving rise to itself. In order to both maintain a supply of mature blood cells and not exhaust HSCs throughout the lifetime of an individual, under steady state, most HSCs remain quiescent and only a small number enter the cell cycle. Quiescence of HSCs is not only critical for protecting the stem cell compartment and sustaining stem cell pools over long periods, but it is also critical for protecting stem cells by minimizing their accumulation of replication-associated mutations. The balance between quiescence and proliferation is tightly controlled by both HSC-intrinsic and -extrinsic mechanisms. In recent years, through reductionistic strategies, a wide variety of molecules or pathways critical for HSC quiescence regulation have been identified. This regulation network involves both positive and negative regulators. Understanding quiescence regulation in HSC is of great importance not only for understanding the physiological foundation of HSCs, but also for understanding the pathophysiological origins of many related disorders. In this article, I will briefly review the current advance in the quiescence regulators for the HSCs. Published by Elsevier Inc.

Mesh:

Substances:

Year:  2011        PMID: 21288477     DOI: 10.1016/j.exphem.2011.01.008

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  33 in total

1.  Notch signaling is necessary to maintain quiescence in adult muscle stem cells.

Authors:  Christopher R R Bjornson; Tom H Cheung; Ling Liu; Pinky V Tripathi; Katherine M Steeper; Thomas A Rando
Journal:  Stem Cells       Date:  2012-02       Impact factor: 6.277

Review 2.  p53-Independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies.

Authors:  Yogen Saunthararajah; Pierre Triozzi; Brian Rini; Arun Singh; Tomas Radivoyevitch; Mikkael Sekeres; Anjali Advani; Ramon Tiu; Frederic Reu; Matt Kalaycio; Ed Copelan; Eric Hsi; Alan Lichtin; Brian Bolwell
Journal:  Semin Oncol       Date:  2012-02       Impact factor: 4.929

3.  Epigenetic reprogramming induces the expansion of cord blood stem cells.

Authors:  Pratima Chaurasia; David C Gajzer; Christoph Schaniel; Sunita D'Souza; Ronald Hoffman
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

4.  Niche-less maintenance of HSCs by 2i.

Authors:  Shigeo Masuda; Mo Li; Juan Carlos Izpisua Belmonte
Journal:  Cell Res       Date:  2013-01-29       Impact factor: 25.617

5.  Bridges between Cell Cycle Regulation and Self-Renewal Maintenance.

Authors:  Patrick Viatour
Journal:  Genes Cancer       Date:  2012-11

6.  Soluble Signals and Remodeling in a Synthetic Gelatin-Based Hematopoietic Stem Cell Niche.

Authors:  Aidan E Gilchrist; Sunho Lee; Yuhang Hu; Brendan A C Harley
Journal:  Adv Healthc Mater       Date:  2019-09-18       Impact factor: 9.933

Review 7.  Divergent modulation of normal and neoplastic stem cells by thrombospondin-1 and CD47 signaling.

Authors:  Sukhbir Kaur; David D Roberts
Journal:  Int J Biochem Cell Biol       Date:  2016-05-06       Impact factor: 5.085

Review 8.  Hematopoietic stem and progenitor cell signaling in the niche.

Authors:  Stephanie N Hurwitz; Seul K Jung; Peter Kurre
Journal:  Leukemia       Date:  2020-10-19       Impact factor: 11.528

9.  Hes1 mediates the different responses of hematopoietic stem and progenitor cells to T cell leukemic environment.

Authors:  Chen Tian; Guoguang Zheng; Zhipan Cao; Qiao Li; Zhenyu Ju; Jinhong Wang; Weiping Yuan; Tao Cheng
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

10.  Exonuclease 1 is a critical mediator of survival during DNA double strand break repair in nonquiescent hematopoietic stem and progenitor cells.

Authors:  Amar Desai; Yulan Qing; Stanton L Gerson
Journal:  Stem Cells       Date:  2014-02       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.